Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value
$149.29−0.74 (-0.49%)
Close on Nov 12, 2026Market cap $10.35BP/E 24.3Yield –
Insulet total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Insulet's total debt was $962.10M at Sep 30, 2026. For fiscal 2025 it was $949.20M, down 31.2% from the year before. Over ten years it grew 18.6% a year on average. The highest annual figure on record is $1.42B in fiscal 2023.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $949.20M | -31.2% |
| FY2024 | Dec 31, 2024 | $1.38B | -2.5% |
| FY2023 | Dec 31, 2023 | $1.42B | +1.0% |
| FY2022 | Dec 31, 2022 | $1.40B | +10.0% |
| FY2021 | Dec 31, 2021 | $1.27B | +20.3% |
| FY2020 | Dec 31, 2020 | $1.06B | +19.3% |
| FY2019 | Dec 31, 2019 | $887.90M | +50.0% |
| FY2018 | Dec 31, 2018 | $592.00M | +4.6% |
| FY2017 | Dec 31, 2017 | $566.17M | +70.1% |
| FY2016 | Dec 31, 2016 | $332.77M | +93.8% |
| FY2015 | Dec 31, 2015 | $171.70M | +4.7% |
| FY2014 | Dec 31, 2014 | $164.02M | +44.3% |
| FY2013 | Dec 31, 2013 | $113.65M | -3.8% |
| FY2012 | Dec 31, 2012 | $118.16M | +8.9% |
| FY2011 | Dec 31, 2011 | $108.54M | +56.3% |
| FY2010 | Dec 31, 2010 | $69.43M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $962.10M | -5.2% |
| Q2 FY2026 | Jun 30, 2026 | $948.40M | -32.2% |
| Q1 FY2026 | Mar 31, 2026 | $948.10M | -44.1% |
| Q4 FY2025 | Dec 31, 2025 | $949.20M | -31.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.01B | -27.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.40B | +0.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.70B | +21.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.38B | -2.5% |
| Q3 FY2024 | Sep 30, 2024 | $1.40B | -1.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.40B | 0.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.40B | +0.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.42B | +1.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.42B | +1.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.40B | -1.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.40B | -1.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.40B | +10.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.41B | +9.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.41B | +12.4% |
| Q1 FY2022 | Mar 31, 2022 | $1.42B | +32.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.27B | +20.3% |
| Q3 FY2021 | Sep 30, 2021 | $1.29B | +39.5% |
| Q2 FY2021 | Jun 30, 2021 | $1.26B | +38.0% |
| Q1 FY2021 | Mar 31, 2021 | $1.07B | +18.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.06B | +19.3% |
| Q3 FY2020 | Sep 30, 2020 | $921.50M | -6.5% |
| Q2 FY2020 | Jun 30, 2020 | $910.20M | +49.9% |
| Q1 FY2020 | Mar 31, 2020 | $899.00M | +49.9% |
| Q4 FY2019 | Dec 31, 2019 | $887.90M | +50.0% |
| Q3 FY2019 | Sep 30, 2019 | $985.77M | +68.7% |
| Q2 FY2019 | Jun 30, 2019 | $607.35M | +5.2% |
| Q1 FY2019 | Mar 31, 2019 | $599.60M | +4.6% |
| Q4 FY2018 | Dec 31, 2018 | $592.00M | +4.6% |
| Q3 FY2018 | Sep 30, 2018 | $584.49M | +69.4% |
| Q2 FY2018 | Jun 30, 2018 | $577.12M | +69.3% |
| Q1 FY2018 | Mar 31, 2018 | $573.33M | +70.2% |
| Q4 FY2017 | Dec 31, 2017 | $566.17M | +70.1% |
| Q3 FY2017 | Sep 30, 2017 | $344.95M | – |
| Q2 FY2017 | Jun 30, 2017 | $340.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $336.76M | – |
| Q4 FY2016 | Dec 31, 2016 | $332.77M | – |
See a number that looks wrong?